InfuSystem Holdings: Pay

InfuSystem Holdings paid its 4 named executives $6.7M in total in FY2025 (Dec). CEO Carrie Lachance was paid $2.9M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Carrie LachanceChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Barry SteeleExecutive Vice President and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Richard DiIorioFormer Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Jerod FunkeExecutive Vice President, Chief Human Resources Officer
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $3.4M. CEO pay of InfuSystem Holdings for that year is not on file.

  1. 1Axogen
  2. 2American Well
  3. 3Cerus
  4. 4Tactile Systems Technology
  5. 5Orthopediatrics
  6. 6Viemed Healthcare
  7. 7KORU Medical Systems
  8. 8Electromed
  9. 9InfuSystem HoldingsNot disclosed
  10. 10Airsculpt TechnologiesNot disclosed
  11. 11Lifecore Biomedical, Inc.Not disclosed
  12. 12National Research CorporationNot disclosed
  13. 13Quipt Home Medical Corp.Not disclosed
  14. 14Sanara MedTechNot disclosed
  15. 15Surmodics, Inc.Not disclosed
  16. 16TELA BioNot disclosed
  17. 17Talkspace, Inc.Not disclosed
  18. 18Xtant Medical Holdings, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.